Adenosquamous carcinoma of the colon with an aberrant MLH1 immunostaining pattern: a diagnostic pitfall in mismatch repair assessment
This paper reports a rare case of adenosquamous carcinoma of the colon with a mismatch repair deficiency profile complicated by a granular MLH1 staining artifact, highlighting the critical need to recognize such patterns to avoid misdiagnosis and ensure accurate therapeutic decision-making.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Cancer is often thought of as a single disease, but within the body, tumors can take on many different shapes and behaviors. One way doctors classify these growths is by looking at the cells under a microscope to see what kind of tissue they resemble. Most colon cancers look like glandular tissue, which is the normal lining of the intestine. However, a very rare type of tumor can contain both glandular cells and squamous cells, the flat cells usually found in the skin or lining of the mouth. This rare mix is called adenosquamous carcinoma. Because these tumors are so uncommon, doctors know less about how they behave and how to treat them compared to standard colon cancers. A critical part of modern cancer care involves checking the tumor's internal machinery, specifically a set of proteins that act like a spell-check system for the cell's genetic code. When this system is broken, the tumor is more likely to respond to a specific type of treatment called immunotherapy. But for this to work, doctors must be able to read the results of their tests correctly, as a confusing signal on a slide can sometimes look like a broken system when it is actually just a visual artifact.
In a recent report, pathologists from Brazil described the case of a sixty-four-year-old woman who came to the hospital with severe abdominal pain and bleeding from the rectum. A scan of her abdomen revealed a large mass in the right side of her colon, measuring thirteen centimeters by eleven centimeters. The tumor had grown aggressively, pressing against the abdominal wall and involving nearby organs. Surgeons removed the mass along with parts of the intestine and reproductive organs. When the tissue was examined under a microscope, it confirmed the presence of the rare adenosquamous carcinoma, with nearly half of the tumor made up of the squamous cell component. The cancer was advanced, having spread to nearby lymph nodes, and the patient unfortunately passed away four months after her surgery due to complications from the disease.
The most significant part of this report, however, lies in the detailed analysis of the tumor's proteins. The medical team tested the tumor for mismatch repair proteins, which are the cellular spell-checkers. They found that one of these proteins, PMS2, was completely missing. Another protein, MLH1, showed a strange, speckled pattern of dots rather than a solid, uniform color. In standard testing, this granular, dot-like pattern is interpreted as a loss of expression, confirming that the spell-check system is broken, a condition known as mismatch repair deficiency. This deficiency is important because it suggests the tumor might be treated successfully with drugs that boost the immune system. The researchers confirmed that the other two spell-check proteins were present and working, supporting the conclusion that the tumor was indeed deficient in this repair system.
The paper highlights a specific danger in reading these test results. The strange, dotted pattern seen in the MLH1 protein was not a sign of a functional system, but rather a known artifact, or visual glitch, caused by the specific tool used to stain the tissue in the lab. If a doctor sees the missing PMS2 and the dotted MLH1, they might mistakenly think that only PMS2 is broken while MLH1 is still present. This specific error could lead to a false suspicion of a hereditary cancer syndrome called Lynch syndrome, which would trigger unnecessary genetic testing for the patient's family. The authors explain that recognizing this specific dotted pattern as a technical quirk associated with a specific antibody clone is essential to avoid misdiagnosis. While they could not re-test the sample with a different tool to prove the point, their analysis of the existing data and the known behavior of this lab tool provides a clear warning.
This case serves as a reminder that even in the high-stakes world of cancer treatment, the details of how a test is performed matter immensely. The tumor in this woman was aggressive and rare, but the lesson extends to all patients with similar findings. Accurate identification of the tumor's molecular profile is the key to unlocking the right treatment, and avoiding the trap of a visual illusion in the microscope is just as important as the treatment itself. By documenting this specific visual pattern, the researchers hope to ensure that other doctors can distinguish between a true genetic error and a harmless laboratory artifact, ensuring that patients receive the correct diagnosis without the burden of unnecessary worry or testing.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.